Do copper peptides work for hair growth?

There is laboratory and small-animal work suggesting follicle enlargement and a longer growth phase, but no substantial human trial and no approval for hair loss anywhere.

Is AHK-Cu or GHK-Cu better for hair?

AHK-Cu is more commonly marketed for hair, but the evidence for it is thinner than for GHK-Cu. Neither has meaningful human trial support for hair growth.

How do copper peptides compare with minoxidil?

Minoxidil has large randomised trials and regulatory approval for androgenetic alopecia. Copper peptides have neither, and no head-to-head study exists.

GHK-Cu (Copper Peptide)

Copper Peptides and Hair

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-312 cited sources

The hair evidence is thinner than the skin evidence. Copper peptides have been reported to enlarge hair follicles and prolong the growth phase in laboratory and small animal work, but there is no substantial human trial. AHK-Cu, a different copper tripeptide, is the one more often marketed for hair.

Key facts

Human trial evidence: Minimal
Reported mechanism: Follicle enlargement, anagen extension
Marketed for hair: More often AHK-Cu
Compared with minoxidil: No head-to-head
Regulatory status for hair loss: Not approved

What has been reported

Copper peptides have been described as enlarging hair follicles and extending the anagen growth phase, largely in cell and small-animal work dating to the 1990s. The proposed mechanism runs through the same matrix remodelling and growth factor signalling invoked for skin. It is plausible and it is not a human efficacy result.

AHK-Cu is usually the hair one

Products aimed at hair more often contain AHK-Cu — alanyl-histidyl-lysine copper — rather than GHK-Cu. It is a different tripeptide with a different first residue, and evidence for it is sparser still. Substituting one for the other on the assumption that copper tripeptides are interchangeable is not supported.

Research material referenced

GHK-Cu 100mg — third-party HPLC tested

View — £24.99

The comparison people actually want

Anyone searching this is usually weighing it against minoxidil or finasteride, which have large randomised trials and regulatory approval for androgenetic alopecia. No head-to-head study exists, and copper peptides have no approval for hair loss anywhere. On evidence quality the two are not close.

Delivery is harder here

Reaching a follicle is a different problem from crossing the stratum corneum, and follicular delivery depends on vehicle and application in ways a simple size argument does not settle. This is another place where the topical evidence for skin does not transfer automatically.

Extended research context

The GHK-Cu (Copper Peptide) deep dive

Deep dive: why the copper ion matters

The GHK tripeptide (Gly-His-Lys) coordinates a Cu²⁺ ion through the imidazole nitrogen of histidine, the terminal α-amino group of glycine, and a deprotonated peptide-bond nitrogen. This near-square-planar geometry is what gives the complex its characteristic deep-blue colour and its redox-modulating chemistry. Uncomplexed GHK is a different molecule pharmacologically — nearly every peer-reviewed study attributes activity to the copper-bound form, which is why suppliers ship the pre-complexed GHK-Cu rather than plain GHK.

GHK-Cu in the transcriptomic literature

The most-cited modern papers on GHK-Cu come from the Pickart & Margolina group and independent transcriptomic re-analyses. GHK-Cu has been reported to modulate expression of >4,000 human genes at nanomolar concentrations in Broad Institute Connectivity Map re-analyses — including genes involved in DNA repair, antioxidant defence, and ECM remodelling. This gene-signature-level activity is the reason GHK-Cu appears in so many research reviews outside of dermatology.

Analytical fingerprinting of GHK-Cu

On reverse-phase HPLC, GHK-Cu elutes as a well-defined peak; free GHK and copper-free peptide impurities are distinguishable. UV-Vis at ~520 nm confirms the copper d-d transition band. Reputable suppliers publish both HPLC (≥98% area) and mass-spec identity (~340 Da complex, 340.4 free peptide) on the batch CoA.

Research applications

▸In vitro fibroblast and keratinocyte gene-expression studies
▸ECM turnover assays (collagen, elastin, decorin, MMP profiling)
▸Wound-healing scratch assays in cell culture models
▸Antioxidant-mechanism studies (copper redox modulation)
▸Formulation R&D: cosmetic and topical carrier compatibility research

Handling checklist

✓Store lyophilised vial at 2–8 °C, protected from light
✓Reconstitute with bacteriostatic or sterile water; expect a blue-tinted solution
✓Avoid contact with reducing agents (ascorbic acid destabilises Cu²⁺)
✓Aliquot reconstituted solution for freeze/thaw minimisation
✓Verify blue colour and CoA HPLC ≥98% before use

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying GHK without copper

Fix: Confirm the CoA reads GHK-Cu (copper-bound); free GHK is a different pharmacology.

✗ Mixing with vitamin C in solution

Fix: Ascorbate reduces Cu²⁺ to Cu⁺ and destabilises the complex — keep them separate.

✗ Exposing to sunlight

Fix: Store in amber vial or foil-wrapped container at 2–8 °C.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

Do copper peptides work for hair growth?: There is laboratory and small-animal work suggesting follicle enlargement and a longer growth phase, but no substantial human trial and no approval for hair loss anywhere.
Is AHK-Cu or GHK-Cu better for hair?: AHK-Cu is more commonly marketed for hair, but the evidence for it is thinner than for GHK-Cu. Neither has meaningful human trial support for hair growth.
How do copper peptides compare with minoxidil?: Minoxidil has large randomised trials and regulatory approval for androgenetic alopecia. Copper peptides have neither, and no head-to-head study exists.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

More GHK-Cu (Copper Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum